117 related articles for article (PubMed ID: 17273758)
21. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells.
Wu Y; Guo SW
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):198-203. PubMed ID: 17376583
[TBL] [Abstract][Full Text] [Related]
22. Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells.
Hajji N; Wallenborg K; Vlachos P; Nyman U; Hermanson O; Joseph B
Oncogene; 2008 May; 27(22):3134-44. PubMed ID: 18071312
[TBL] [Abstract][Full Text] [Related]
23. Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies.
Blaheta RA; Michaelis M; Driever PH; Cinatl J
Med Res Rev; 2005 Jul; 25(4):383-97. PubMed ID: 15637697
[TBL] [Abstract][Full Text] [Related]
24. All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells.
Huang H; Wu D; Fu J; Chen G; Chang W; Chow HC; Leung AY; Liang R
Eur J Haematol; 2009 Sep; 83(3):191-202. PubMed ID: 19467017
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
Travaglini L; Vian L; Billi M; Grignani F; Nervi C
Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
[TBL] [Abstract][Full Text] [Related]
26. Valproic acid induces caspase 3-mediated apoptosis in microglial cells.
Dragunow M; Greenwood JM; Cameron RE; Narayan PJ; O'Carroll SJ; Pearson AG; Gibbons HM
Neuroscience; 2006 Jul; 140(4):1149-56. PubMed ID: 16600518
[TBL] [Abstract][Full Text] [Related]
27. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
Sinn DI; Kim SJ; Chu K; Jung KH; Lee ST; Song EC; Kim JM; Park DK; Kun Lee S; Kim M; Roh JK
Neurobiol Dis; 2007 May; 26(2):464-72. PubMed ID: 17398106
[TBL] [Abstract][Full Text] [Related]
28. Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways.
Angelucci A; Valentini A; Millimaggi D; Gravina GL; Miano R; Dolo V; Vicentini C; Bologna M; Federici G; Bernardini S
Anticancer Drugs; 2006 Nov; 17(10):1141-50. PubMed ID: 17075313
[TBL] [Abstract][Full Text] [Related]
29. Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid.
Kikukawa Y; Okuno Y; Tatetsu H; Nakamura M; Harada N; Ueno S; Kamizaki Y; Mitsuya H; Hata H
Int J Oncol; 2008 Oct; 33(4):807-14. PubMed ID: 18813795
[TBL] [Abstract][Full Text] [Related]
30. Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo.
Sami S; Höti N; Xu HM; Shen Z; Huang X
J Biochem; 2008 Sep; 144(3):357-62. PubMed ID: 18515856
[TBL] [Abstract][Full Text] [Related]
31. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.
Jones J; Bentas W; Blaheta RA; Makarevic J; Hudak L; Wedel S; Probst M; Jonas D; Juengel E
Int J Mol Med; 2008 Sep; 22(3):293-9. PubMed ID: 18698487
[TBL] [Abstract][Full Text] [Related]
32. Valproic acid for the treatment of myeloid malignancies.
Kuendgen A; Gattermann N
Cancer; 2007 Sep; 110(5):943-54. PubMed ID: 17647267
[TBL] [Abstract][Full Text] [Related]
33. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
34. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
[TBL] [Abstract][Full Text] [Related]
35. Effect of valproic acid, a histone deacetylase inhibitor, on cell death and molecular changes caused by low-dose irradiation.
Záskodová D; Rezácová M; Vávrová J; Vokurková D; Tichy A
Ann N Y Acad Sci; 2006 Dec; 1091():385-98. PubMed ID: 17341630
[TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
37. Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells.
Catalano MG; Fortunati N; Pugliese M; Costantino L; Poli R; Bosco O; Boccuzzi G
J Clin Endocrinol Metab; 2005 Mar; 90(3):1383-9. PubMed ID: 15585556
[TBL] [Abstract][Full Text] [Related]
38. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
Rikiishi H; Shinohara F; Sato T; Sato Y; Suzuki M; Echigo S
Int J Oncol; 2007 May; 30(5):1181-8. PubMed ID: 17390020
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of beta1 integrins in renal carcinoma cell lines exposed to the differentiation inducer valproic acid.
Oertl A; Relja B; Makarevic J; Weich E; Höfler S; Jones J; Jonas D; Bratzke H; Baer PC; Blaheta RA
Int J Mol Med; 2006 Aug; 18(2):347-54. PubMed ID: 16820945
[TBL] [Abstract][Full Text] [Related]
40. Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions.
Seet LF; Teng E; Lai YS; Laning J; Kraus M; Wnendt S; Merchav S; Chan SL
Eur J Haematol; 2009 Feb; 82(2):124-32. PubMed ID: 19067743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
